The impact of gastrointestinal symptoms on health status in patients with cardiovascular disease

Alimentary Pharmacology and Therapeutics

Volumn 17, Issue 7, 2003, Pages 881-885

  Laheij, R J F ^a   Van Rossum, L G M ^a   Krabbe, P F M ^b   Jansen, J B M J ^a   Verheugt, F W A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY CARE UNIT; DAILY LIFE ACTIVITY; GASTROINTESTINAL SYMPTOM; HEALTH STATUS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LOCOMOTION; MAJOR CLINICAL STUDY; NETHERLANDS; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; SELF CARE; SELF CONCEPT;

AGED; ANXIETY DISORDERS; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER; FEMALE; GASTROINTESTINAL DISEASES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PAIN; QUESTIONNAIRES; SELF CONCEPT;

EID: 0037395296     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01542.x     Document Type: Article

References (17)

1. Nandurkar S, Talley NJ, Xia H, Mitchell H, Hazel S, Jones M. Dyspepsia in the community is linked to smoking and aspirin use but not to H. pylori infection. Arch Intern Med 1998; 158: 1427-33.
2. Voutilainen M, Mantynen T, Farkklia M, Juhola M, Sipponen P. Impact of NSAID and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Scand J Gastroenterol 2001; 36: 817-21.
3. Jones RH, Tait CL. Gastrointestinal side-effects of NSAIDs in the community. Br J Clin Pract 1995; 49: 67-70.
4. Laheij RJF, Jansen JBMJ, Verbeek ALM, Verheugt FWA. H. pylori as a risk factor for gastrointestinal symptoms in patients using aspirin for ischaemic heart disease. Aliment Pharmacol Ther 2001; 15: 1055-61.
5. Roderick PJ, Wilkes HC, Meade TW. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol 1993; 35: 219-26.
6. Enck P, Dubois D, Marquis P. Health status in patients with upper gastrointestinal symptoms: results from the domestic international gastroenterology surveillance study. Scand J Gastroenterol 1999; 34: 48-54.
7. Mones J, Adan A, Segu JL, et al. Health status in functional dyspepsia. Dig Dis Sci 2002; 47: 20-6.
8. Frank L, Kleinman L, Ganoczy D, et al. Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and health status. Dig Dis Sci 2000; 45: 809-18.
9. Beck CA, Joseph L, Belisle P, Pilote L. Predictors of health status 6 months and 1 year after acute myocardial infarction. Am Heart J 2001; 142: 271-9.
10. Brown N, Melville M, Gray D. et al. Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart 1999; 81: 352-8.
11. Kelly JP, Laslo A, Kaufman DW, et al. Major upper gastrointestinal bleeding and the use of calcium channel blockers. Lancet 1999; 353: 559.
12. Abajo FJ, Rodriguez LAG. Risk of upper gastrointestinal bleeding and perforation associated with low dose aspirin as plain and enteric-coated formulations. BMC Clin Pharmacol 2001; 1: 1.
13. Van Agt HME, Essink-bot ML, Krabbe PFM, Bonsel GJ. Test-retest reliability of health state validations collected with the EuroQol questionnaire. Soc Sci Med 1994; 39: 1537-44.
14. Essink-bot ML, Krabbe PFM, Bonsel GJ, Aaronson N. An empirical comparison of four generic health status measures - The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument. Med Care 1997; 35: 522-37.
15. Bijlsma JW. Treatment of NSAID-induced gastrointestinal lesions with cimetidine. Aliment Pharmacol Ther 1988; 2(Suppl. 1): 85-95.
16. van Groenendaal JHLM, Markusse HM, Dijkmans BAC, Breedveld FC. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis. Clin Rheumatol 1996; 15: 450-6.
17. Hawkey CJ, Karrasch JA, Szczepanski BS, et al. Omeprazole compared with misoprostol for ulcers associated with NSAIDs. N Engl J Med 1998; 338: 727-34.